Kevin D Deane1. 1. Division of Rheumatology, University of Colorado School of Medicine, 1775 Aurora Court, Mail Stop B-115, Aurora, CO, 80045, USA. Kevin.Deane@UCDenver.edu.
Abstract
PURPOSE OF REVIEW: This review is to provide an update on the current understanding of rheumatoid arthritis (RA) development related to disease development prior to the onset clinically apparent synovitis and opportunities for disease prevention. RECENT FINDINGS: A growing number of studies have demonstrated that serum elevations of autoantibodies rheumatoid factor and antibodies to citrullinated protein/peptide antigens (ACPA) are highly predictive of future development of IA/RA. This has underpinned the development of several prevention trials in RA. The full results from most of these prevention trials are pending, but ultimately, they should further inform several critical issues in RA prevention including identification and enrollment of individuals at high risk of imminent RA, the efficacy, safety and cost-effectiveness of prevention, and potentially the identification of new targets for prevention. Results from studies in RA prevention as well as other ongoing natural history studies of RA will help to change the paradigm of how RA is managed, potentially adding prevention to the possibilities for management.
PURPOSE OF REVIEW: This review is to provide an update on the current understanding of rheumatoid arthritis (RA) development related to disease development prior to the onset clinically apparent synovitis and opportunities for disease prevention. RECENT FINDINGS: A growing number of studies have demonstrated that serum elevations of autoantibodies rheumatoid factor and antibodies to citrullinated protein/peptide antigens (ACPA) are highly predictive of future development of IA/RA. This has underpinned the development of several prevention trials in RA. The full results from most of these prevention trials are pending, but ultimately, they should further inform several critical issues in RA prevention including identification and enrollment of individuals at high risk of imminent RA, the efficacy, safety and cost-effectiveness of prevention, and potentially the identification of new targets for prevention. Results from studies in RA prevention as well as other ongoing natural history studies of RA will help to change the paradigm of how RA is managed, potentially adding prevention to the possibilities for management.
Entities:
Keywords:
Antibodies to citrullinated protein antigens (ACPA); Autoantibodies; Preclinical; Rheumatoid arthritis; Rheumatoid arthritis prevention; Rheumatoid factor
Authors: Natalia Wegner; Karin Lundberg; Andrew Kinloch; Benjamin Fisher; Vivianne Malmström; Marc Feldmann; Patrick J Venables Journal: Immunol Rev Date: 2010-01 Impact factor: 12.988
Authors: Lotte A van de Stadt; Wouter H Bos; Marlies Meursinge Reynders; Helen Wieringa; Franktien Turkstra; Conny J van der Laken; Dirkjan van Schaardenburg Journal: Arthritis Res Ther Date: 2010-05-20 Impact factor: 5.156
Authors: Cesar Ramos-Remus; Jose Dionisio Castillo-Ortiz; Luis Aguilar-Lozano; Jorge Padilla-Ibarra; Carlos Sandoval-Castro; Cesar Omar Vargas-Serafin; Hector de la Mora-Molina; Ariadna Ramos-Gomez; Adriana Sanchez-Ortiz; Hilario Avila-Armengol; Francisco Javier Aceves-Avila Journal: Arthritis Rheumatol Date: 2015-11 Impact factor: 10.995
Authors: Ryan W Gan; Elizabeth A Bemis; M Kristen Demoruelle; Christopher C Striebich; Stacey Brake; Marie L Feser; LauraKay Moss; Michael Clare-Salzler; V Michael Holers; Kevin D Deane; Jill M Norris Journal: Rheumatology (Oxford) Date: 2017-12-01 Impact factor: 7.580
Authors: Ryan W Gan; M Kristen Demoruelle; Kevin D Deane; Michael H Weisman; Jane H Buckner; Peter K Gregersen; Ted R Mikuls; James R O'Dell; Richard M Keating; Tasha E Fingerlin; Gary O Zerbe; Michael J Clare-Salzler; V Michael Holers; Jill M Norris Journal: Ann Rheum Dis Date: 2016-05-17 Impact factor: 27.973
Authors: Maria J H de Hair; Robert B M Landewé; Marleen G H van de Sande; Dirkjan van Schaardenburg; Lisa G M van Baarsen; Danielle M Gerlag; Paul P Tak Journal: Ann Rheum Dis Date: 2012-10-27 Impact factor: 19.103